Device Trial Radar · NCT02228889
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Last checked: Nov 19, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
46
Actual
Start
Jan 2015
Primary completion
Mar 27, 2025
Study completion Mar 27, 2025
Sponsor
- Lead sponsor
- Jeffrey JanisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 29, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to compare the clinical outcomes of two commonly used, FDA-approved biologic meshes in hernia repair and abdominal wall reconstruction (Strattice and XenMatrix). The two meshes are derived from pig skin from which cells have been removed and which have been sterilized. The two meshes are made by two different companies using different processes.
Conditions
- Hernia, Ventral
- Intestinal Fistula
- Fibromatosis, Abdominal
Interventions
Abdominal wall reconstruction with StratticeProcedure
Abdominal wall reconstruction using Strattice
Assess pain intensity at last office visit preoperativelyOther
Assess patient pain intensity preoperatively using the PROMIS Pain Intensity survey (average of 1-3 weeks preoperatively)
Assess pain interference at last office visit preoperativelyOther
Assess pain interference preoperatively using the PROMIS pain interference survey (average of 1-3 weeks preoperatively)
Assess physical functioning at last office visit preoperativelyOther
Assess physical functioning preoperatively using the PROMIS physical functioning survey (average of 1-3 weeks preoperatively)
Assess patient quality of life at last office visit preoperativelyOther
Assess patient quality of life preoperatively, using the HerQLes survey (average of 1-3 weeks preoperatively)
Assess patient pain intensity postoperativelyOther
Assess patient pain intensity at 1 year postoperatively using the PROMIS Pain Intensity survey
Assess pain interference postoperativelyOther
Assess pain interference at 1 year postoperatively using the PROMIS Pain Interference survey
Assess physical functioning postoperativelyOther
Assess physical functioning at 1 year postoperatively using the PROMIS Physical Functioning Survey
Assess quality of life postoperativelyOther
Assess quality of life at 1 year postoperatively using the HerQLes survey
Assess hernia recurrence at 30 days postoperativelyOther
Assess hernia recurrence at 30 days
Assess bulge at 30 days postoperativelyOther
Assess bulge at 30 days
Assess Surgical Site Occurrences at 30 days postoperativelyOther
Assess Surgical Site Occurrences at 30 days
Assess hernia recurrence at 1 year postoperativelyOther
Assess hernia recurrence at 1 year postoperatively
Assess bulge at 1 year postoperativelyOther
Assess bulge at 1 year postoperatively
Assess Surgical Site Occurrences at 1 year postoperativelyOther
Assess Surgical Site Occurrences at 1 year postoperatively
Assess overall complications at 30 days postoperativelyOther
Assess overall complications at 1 year postoperativelyOther
Abdominal wall reconstruction with XenMatrixProcedure
Abdominal wall reconstruction with XenMatrix
StratticeDevice
Strattice mesh
XenMatrixDevice
Xenmatrix mesh
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Surgical Site Occurrences (SSOs) at 6 WeekTime frame: 6 week postoperatively
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Ohio State University Wexner Medical Center
Columbus, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.